cas 80875-94-1, (1b,3a,5b,7a,12a)-1,3,7,12-tetrahydroxy-Cholan-24-oic acid

Articles about 80875-94-1Total 4 be found

ROR gamma modulators
The present invention relates to compounds of formula I, or a pharmaceutically acceptable salt thereof, for use in the treatment or prevention, suppression or amelioration of a disease mediated by the ROR gamma receptor in a subject in need thereof, in particular diabetes and diabetes-related disorders, specifically type II diabetes, methods of their production, as well as methods of treatment or prevention of such diseases.
-
Page/Page column 43; 44

(2017/10/25)

ROR GAMMA MODULATORS
The present invention relates to compounds of formula I, or a pharmaceutically acceptable salt thereof, for use in the treatment or prevention, suppression or amelioration of a disease mediated by the ROR gamma receptor in a subject in need thereof, in particular diabetes and diabetes- related disorders, specifically type II diabetes, methods of their production, as well as methods of treatment or prevention of such diseases.
-
Page/Page column 57

(2013/04/10)

Synthesis of the 1 beta-hydroxylated bile acids, unusual bile acids in human biological fluids.
-
Tohma,Mahara,Takeshita,Kurosawa,Ikegawa
p. 2890 - 2899
(2007/10/02)

Synthesis of the 1β-hydroxylated bile acids and identification of 1β,3α,7α-trihydroxy- and 1β,3α,7α,12α-tetrahydroxy-5β-cholan-24-oic acids in human meconium
-
Tohma,Mahara,Takeshita,Kurosawa,Ikegawa,Nittono
p. 3071 - 3073
(2007/10/02)